´ëÇÑÀ忬±¸ÇÐȸ The 8th Annual Meeting of Asian Organization for Crohn¡¯s & Colitis : 2020-12-18±³À°ÀÏÀÚ : 2020-12-18
±³À°Àå¼Ò : º¤½ºÄÚ ÄÁº¥¼ÇȦ
±³À°ÁÖÁ¦ :
The 8th Annual Meeting of Asian Organization for Crohn¡¯s & Colitis ÁÖÃÖ±â°ü : ´ëÇÑÀ忬±¸ÇÐȸ
´ã´çÀÚ : ±èº¸¶÷
¿¬¶ôó : 02-957-6145
À̸ÞÀÏ :
thekasid2@gmail.com ±³À°Á¾·ù : ³»°úÀÇ»çÇÐ, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥, ±âŸ,
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 7 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 150,000¿ø
ºñ°í AOCC Member Pre-Registration US$100/ On-site Registration US$120, Non-Member Pre-Registration US$120/ On-site Registration US$150, Trainee / Resident / Nurse / Pharmacist / Researcher / Exhibitor Pre-Registration US$70/ On-site Registration US$90
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12¿ù 18ÀÏ Paradise Hotel Busan, Sicily Room 07:00~07:40 Evolving therapeutic goals in ulcerative colitis: Important role of 5-ASA Silvio Danese(Humanitas Research Hospital Italy)
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 08:30~08:50 Current national guidelines in Asian countries Choon Jin Ooi(Duke-NUS Medical School Singapore)
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 08:50~09:10 International guidelines in Asia: Are they feasible and necessary? Katsuyoshi Matsuoka(Toho University Sakura Medical Center Japan)
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 09:10~09:30 Lessons from ECCO for developing international guidelines Simon Travis(University of Oxford United Kingdom)
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 09:30~09:50 How to develop Asian guidelines for IBD? ¹Úµ¿ÀÏ(¼º±Õ°üÀÇ´ë)
Åä·Ð 12¿ù 18ÀÏ 101-104/106-109 09:50~10:00 Discussion All()
ÈÞ½Ä 12¿ù 18ÀÏ 10:00~10:30 ()
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 10:30~10:50 Choosing the right therapy after conventional treatment failure ÃÖâȯ(Áß¾ÓÀÇ´ë)
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 10:50~11:10 Controversies and solutions in non-responders to anti-TNF Mark Silverberg(Mount Sinai Hospital Canada)
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 11:10~11:30 De-escalation of therapy in patients with quiescent IBD Taku Kobayashi(Kitasato University Kitasato Institute Hospital Japan)
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 11:30~11:45 Abstract 1-Oral Presentation Abstract()
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 11:45~12:00 Abstract 2-Oral Presentation Abstract()
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 12:00~12:30 Tight control – evidence for optimizing treatment Edward V. Loftus Jr.(Mayo Clinic USA)
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 12:30~13:00 Choosing a IBD drug and getting the most out of it Taku Kobayashi(Kitasato University Kitasato Institute Hospital Japan)
ÈÞ½Ä 12¿ù 18ÀÏ 13:00~13:30 ()
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 13:30~13:50 Big data research: IBD fact sheet in Korea ÀÌ°¹®(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 13:50~14:10 Stem cell therapy: Translating dreams into clinical practice Ryuichi Okamoto(Tokyo Medical and Dental University Japan)
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 14:10~14:30 Environmental triggers: Which one should we consider first? Miguel Regueiro(Cleveland Clinic USA)
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 14:30~14:50 Prevention of IBD: Is it possible? Mark Silverberg(Mount Sinai Hospital Canada)
Åä·Ð 12¿ù 18ÀÏ 101-104/106-109 14:50~15:00 Discussion All()
ÈÞ½Ä 12¿ù 18ÀÏ 15:00~15:30 ()
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 15:30~15:50 Unmet needs in IBD research and practice ÁøÀ±ÅÂ(°í·ÁÀÇ´ë)
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 15:50~16:10 Quality of care in IBD: A holistic approach Edward V. Loftus Jr.(Mayo Clinic USA)
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 16:10~16:30 Suggestions for collaboration between ECCO and AOCC Laurent Peyrin-Biroulet(Nancy University Hospital France)
±³À°½Ã°£ 12¿ù 18ÀÏ 101-104/106-109 16:30~16:50 Future perspectives for AOCC Minhu Chen(The First Affiliated Hospital Sun Yat-sen University China)
Åä·Ð 12¿ù 18ÀÏ 101-104/106-109 16:50~17:00 Discussion All()